Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.621.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.125 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.103.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.92 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.122.4 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.101 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.57NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.49NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.69NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.6.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.34NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.58NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAY.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.71NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CL.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DB.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CZ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.47NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FK.1.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.26.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DS.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BZ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CK.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used